Pfizer grants access to anti Covid pill license
Share
November 16, 2021 Pfizer asks American authorities for authorization for the emergency use of its Covid pill.
Pfizer stated in a note, noting that it had submitted the request to the Food and Drug Administration.
"There is an urgent need for life-saving treatment options. The efficacy shown in recent clinical studies by
Paxlovid
highlights the essential role that oral antiviral therapies can play in the battle against Covid," says Pfizer CEO. , Albert Bourla.